Have a question or topic idea for The Life Science Report? Submit it here.
Living Medicines – Current and Future Uses of Car T Cells
In this episode of Back Bay’s industry podcast, The Life Science Report, Dr. Peter Bak is joined by Mike Bogetofte Barnkob, a doctor with the Department of Clinical Immunology at Odense University Hospital in Denmark and a research fellow at the University of Southern Denmark, to discuss current perspectives—clinical, scientific and manufacturing—on the cell therapy space.
Dr. Barnkob’s expertise spans basic and clinical immunology, with a particular interest in advanced cellular modalities, such as chimeric antigen or CAR T-cells. He studied at the Massachusetts Institute of Technology, in Back Bay’s hometown, and completed his PhD at Oxford University.
Topics in this podcast include:
The current clinical and academic uses of CAR T-cells and where they are headed in the near-term
How cellular therapies factor into a robust and thriving public healthcare-based system
Ongoing questions of pricing and reimbursement
Challenges and approval processes in getting these "living medicines" to people
Hurdles and considerations when building a Good Manufacturing Practice (GMP) cellular facility
Do you have a question about development in the cell therapy space? Drop Back Bay a line.
Make sure to subscribe to our podcast and follow Back Bay Life Science Advisors on LinkedIn.
Subscribe:
Apple Podcasts | Libsyn | Spotify | Stitcher
IN THIS EPISODE
Mike Bogetofte, MD, PhD
Department of Clinical Immunology
at Odense University Hospital in Denmark